- You need to sign in or sign up before continuing.
0
0
7/27/23 at 2:12pm
Organization
Multiple Sclerosis News Today
35 words
0
Comments
Glatiramer acetate, Mavenclad, and rituximab made the list due to the ability to safely and cost-effectively slow or delay MS progression.
You are the first to view
https://multiplesclerosisnewstoday.com/news-posts/2023/07/27/three-ms-therapies-have-been-listed-as-who-essential-medicines/
Create an account
or login to join the discussion